Further evidence has shown that PARP inhibition triggers p53-dependent cellular senescence in a PTEN-deficient PCa setting and induces an apoptotic response upon the combined loss of PTEN and TP53. The gene discussed is TP53; the disease is posterior cortical atrophy.